Toxicity and Outcome of Whole Breast Hypofractionated Radiotherapy: a Single Institution Experience (Ipomammella)
Toxicity and Outcome of Whole Breast Hypofractionated Radiotherapy Without Boost: Results of a Homogeneous Single Institution Experience
Sponsor: IRCCS San Raffaele
A observational or N/A phase clinical study on Breast Cancer and Quality of Life, this trial is ongoing. The trial is conducted by IRCCS San Raffaele and has accumulated 12 data snapshots since 2016. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
12 versions recorded-
May 2025 — Present [monthly]
Active Not Recruiting
-
Sep 2024 — May 2025 [monthly]
Active Not Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting
-
Jul 2023 — Jul 2024 [monthly]
Active Not Recruiting
-
Feb 2023 — Jul 2023 [monthly]
Active Not Recruiting
▶ Show 7 earlier versions
-
Feb 2022 — Feb 2023 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Jan 2021 — Feb 2022 [monthly]
Recruiting
-
Mar 2020 — Jan 2021 [monthly]
Recruiting
-
Sep 2018 — Mar 2020 [monthly]
Recruiting
-
Jun 2018 — Sep 2018 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Apr 2017 — Apr 2018 [monthly]
Recruiting NA
First recorded
Nov 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- IRCCS San Raffaele
For direct contact, visit the study record on ClinicalTrials.gov .